Xilio Therapeutics, Inc.
XLO
$0.71
$0.00981.40%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 55.29M | 61.26M | 74.95M | 33.98M | 44.70M |
| Total Receivables | 2.00M | -- | -- | 30.00M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.94M | 2.05M | 3.06M | 5.21M | 3.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 60.23M | 63.31M | 78.01M | 69.19M | 48.13M |
|
|
|||||
| Total Current Assets | 60.23M | 63.31M | 78.01M | 69.19M | 48.13M |
| Net Property, Plant & Equipment | 9.06M | 9.57M | 10.00M | 10.54M | 11.20M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.78M | 1.78M | 1.86M | 2.88M | 1.60M |
| Total Assets | 71.08M | 74.66M | 89.87M | 82.61M | 60.93M |
|
|
|||||
| Total Accounts Payable | 2.57M | 972.00K | 1.26M | 746.00K | 1.05M |
| Total Accrued Expenses | 9.98M | 9.79M | 9.74M | 8.00M | 10.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.19M | 1.15M | 1.12M | 1.11M | 4.41M |
| Total Finance Division Other Current Liabilities | 13.52M | 26.11M | 26.52M | 21.73M | -- |
| Total Other Current Liabilities | 13.52M | 26.11M | 26.52M | 21.73M | -- |
| Total Current Liabilities | 27.26M | 38.02M | 38.64M | 31.58M | 15.96M |
|
|
|||||
| Total Current Liabilities | 27.26M | 38.02M | 38.64M | 31.58M | 15.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.95M | 7.26M | 7.57M | 7.86M | 8.14M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.26M | 8.40M | 10.25M | 17.40M | -- |
| Total Liabilities | 53.48M | 53.68M | 56.46M | 56.84M | 24.10M |
|
|
|||||
| Common Stock & APIC | 401.35M | 391.63M | 390.06M | 368.48M | 362.34M |
| Retained Earnings | -383.75M | -370.66M | -356.64M | -342.72M | -325.51M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 17.60M | 20.97M | 33.42M | 25.77M | 36.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.60M | 20.97M | 33.42M | 25.77M | 36.83M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.60M | 20.97M | 33.42M | 25.77M | 36.83M |
|
|
|||||
